Caplin Steriles Limited, a subsidiary of Caplin Point Laboratories Limited, has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA). The approval is for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution (Eye Drops), 0.2%/0.5%, available in 5mL, 10mL, and 15mL fill presentations. This product is a generic therapeutic equivalent of the Reference Listed Drug (RLD) COMBIGAN, manufactured by AbbVie Inc.